文章摘要
王志恒刘晓艳△ 张彬徐文彬唐慧琳.肿瘤标志物在卵巢恶性肿瘤早期误诊预防中的价值[J].,2012,12(12):2302-2304
肿瘤标志物在卵巢恶性肿瘤早期误诊预防中的价值
Value of Tumor Markers in Ovarian Cancer is Misdiagnosed Prevention
  
DOI:
中文关键词: 卵巢癌  早期  糖类抗原联合检测  鉴别诊断
英文关键词: Ovarian cancer  Early stage  Carbohydrate antigen joint detection  Differential diagnosis
基金项目:
作者单位
王志恒刘晓艳△ 张彬徐文彬唐慧琳 复旦大学附属妇产科医院检验科 
摘要点击次数: 874
全文下载次数: 0
中文摘要:
      目的:探讨糖类抗原CA125、CEA 与CA199 联合检测对卵巢癌有一定的鉴别诊断价值。方法:应用化学发光免疫法对126 例经病理查证实的卵巢癌患者(试验组)、104 例良性肿瘤患者(对照组)进行血清CA125、CEA 与CA199 检测。结果:试验组血清 检测结果和阳性率均明显高于对照组(P<0.01),联合检测阳性率高于单项检测(P<0.01)。结论:应用检验医学进行CA125、CEA 与CA199 联合检测对卵巢癌有一定的鉴别诊断价值。可降低误诊率。
英文摘要:
      Objective: To investigate the value of combination detection of carbohydrate antigen CA125, CEA and CA199 for differential diagnosis on patients with ovarian cancer. Methods: Chemiluminescence immunoassay was used to detect serum CA125, CEA and CA199 levels of the 126 patients who were confirmed with ovarian cancer by pathology investigation (experimental group) and 104 patients with benign tumors (control group). Results: The serum test results and the positive rate of the experimental group was significantly higher than that of control group (P <0.01). Combination detection showed a higher positive rate (P <0.01) than the individual detection. Conclusion: Combination detection of CA125, CEA and CA199 had significance in the differential diagnosis of ovarian cancer. It can reduce the rate of misdiagnosis.
查看全文   查看/发表评论  下载PDF阅读器
关闭